Index RUT
P/E -
EPS (ttm) -2.42
Insider Own 28.66%
Shs Outstand 45.92M
Perf Week -4.49%
Market Cap 598.34M
Forward P/E -
EPS next Y -2.60
Insider Trans -20.03%
Shs Float 37.18M
Perf Month -14.96%
Income -108.53M
PEG -
EPS next Q -0.55
Inst Own 58.63%
Short Float 22.35%
Perf Quarter 145.82%
Sales 7.84M
P/S 76.32
EPS this Y 4.34%
Inst Trans -1.95%
Short Ratio 6.32
Perf Half Y 149.02%
Book/sh 3.02
P/B 3.80
EPS next Y -14.23%
ROA -44.57%
Short Interest 8.31M
Perf Year -1.46%
Cash/sh 3.43
P/C 3.35
EPS next 5Y -
ROE -61.29%
52W Range 3.35 - 16.40
Perf YTD 118.25%
Dividend Est. -
P/FCF -
EPS past 5Y -44.06%
ROI -75.12%
52W High -30.00%
Beta 0.82
Dividend TTM -
Quick Ratio 5.42
Sales past 5Y -5.84%
Gross Margin 40.15%
52W Low 242.69%
ATR (14) 0.97
Dividend Ex-Date -
Current Ratio 5.42
EPS Y/Y TTM 2.14%
Oper. Margin -1509.93%
RSI (14) 50.36
Volatility 6.88% 7.86%
Employees 110
Debt/Eq 0.05
Sales Y/Y TTM -46.11%
Profit Margin -1383.40%
Recom 1.22
Target Price 22.14
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q -7.60%
Payout -
Rel Volume 0.57
Prev Close 12.01
Sales Surprise 29.31%
EPS Surprise 6.54%
Sales Q/Q -18.17%
Earnings May 06 BMO
Avg Volume 1.32M
Price 11.48
SMA20 -3.00%
SMA50 11.75%
SMA200 84.76%
Trades
Volume 753,395
Change -4.41%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-26-24 Upgrade
TD Cowen
Market Perform → Outperform
Nov-20-23 Resumed
JP Morgan
Neutral
Jul-25-23 Downgrade
TD Cowen
Outperform → Market Perform
May-01-23 Upgrade
BofA Securities
Underperform → Neutral
$9 → $12
Apr-26-23 Resumed
Canaccord Genuity
Buy
$24
Jan-06-23 Downgrade
BofA Securities
Buy → Underperform
$22 → $9
Oct-24-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$30
Jan-31-22 Initiated
Jefferies
Buy
$50
Dec-03-21 Initiated
BofA Securities
Buy
$43
Nov-22-21 Upgrade
JP Morgan
Neutral → Overweight
$41
May-18-21 Initiated
UBS
Neutral
$35
May-10-21 Upgrade
Wedbush
Neutral → Outperform
Apr-26-21 Resumed
Credit Suisse
Outperform
$58
Feb-10-21 Downgrade
Wedbush
Outperform → Neutral
Dec-15-20 Resumed
H.C. Wainwright
Buy
$70
Dec-11-20 Reiterated
Needham
Buy
$48 → $56
Oct-23-20 Initiated
Cantor Fitzgerald
Overweight
$49
Sep-29-20 Resumed
JP Morgan
Neutral
$34
Sep-29-20 Initiated
Needham
Buy
$42
Dec-18-19 Initiated
Wedbush
Outperform
$31
Show Previous Ratings
May-07-24 09:04PM
10:30AM
May-06-24 11:53AM
08:05AM
07:00AM
10:21AM
Loading…
Apr-29-24 10:21AM
08:00AM
Apr-25-24 10:01AM
Apr-23-24 07:45AM
Apr-17-24 08:00AM
Apr-04-24 04:30PM
Mar-27-24 11:40PM
08:50AM
Mar-26-24 04:07PM
11:20AM
07:54AM
Loading…
07:54AM
07:49AM
Mar-25-24 09:53PM
05:10PM
04:01PM
04:01PM
Feb-29-24 08:50AM
Feb-26-24 10:00AM
Feb-25-24 01:37PM
Feb-19-24 02:31PM
Feb-15-24 09:55AM
06:59AM
Jan-17-24 04:30PM
Jan-08-24 08:00AM
Jan-04-24 04:30PM
10:29AM
Loading…
Jan-02-24 10:29AM
(Yahoo Finance Video) +11.41%
Dec-14-23 09:55AM
Dec-01-23 09:00AM
Nov-21-23 08:00AM
Nov-09-23 05:48AM
Nov-07-23 07:00AM
Oct-17-23 04:30PM
Sep-21-23 08:00AM
Sep-20-23 04:30PM
Sep-05-23 07:00AM
Aug-16-23 01:00PM
Aug-08-23 06:02AM
Aug-07-23 08:15AM
07:00AM
Aug-02-23 08:00AM
Jul-25-23 02:32PM
07:00AM
Jul-21-23 07:30AM
Jul-05-23 01:20PM
Jun-21-23 04:22AM
Jun-16-23 04:30PM
Jun-14-23 09:55AM
May-09-23 09:55AM
06:04AM
May-06-23 08:03AM
May-04-23 10:00AM
08:55AM
07:00AM
May-03-23 08:00AM
May-02-23 10:02AM
Apr-25-23 07:00AM
Mar-28-23 10:40AM
Mar-15-23 07:00AM
Mar-06-23 08:15AM
07:00AM
Feb-27-23 04:30PM
Feb-07-23 08:00AM
Jan-26-23 05:59AM
Jan-09-23 08:00AM
Jan-04-23 08:00AM
Dec-02-22 09:00AM
Nov-29-22 07:30AM
Nov-14-22 01:02PM
08:25AM
07:00AM
Nov-10-22 08:32AM
07:30AM
Nov-07-22 09:55AM
Oct-19-22 10:02AM
Aug-25-22 07:30AM
Aug-19-22 06:40AM
Aug-10-22 09:55AM
Aug-09-22 11:54AM
Aug-08-22 08:15AM
07:00AM
Jun-01-22 02:00PM
(American City Business Journals)
07:30AM
May-12-22 07:44AM
May-10-22 07:00AM
May-05-22 10:06AM
May-02-22 04:35PM
Apr-07-22 07:30AM
Apr-05-22 07:30AM
Mar-10-22 07:00AM
Mar-01-22 09:43AM
Feb-28-22 10:00AM
07:30AM
Feb-10-22 10:00AM
Jan-13-22 11:13AM
Jan-11-22 11:56AM
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ticho Barry CHIEF MEDICAL OFFICER May 01 '24 Option Exercise 0.60 10,000 6,000 12,485 May 03 04:24 PM Ticho Barry CHIEF MEDICAL OFFICER May 01 '24 Sale 11.37 10,000 113,653 2,485 May 03 04:24 PM Skorpios Trust 10% Owner Apr 17 '24 Sale 11.60 3,600,000 41,760,000 10,843,681 Apr 18 04:16 PM Nash Huw M. COO & CBO Apr 01 '24 Option Exercise 0.40 50,000 20,000 61,329 Apr 03 04:19 PM Ticho Barry CHIEF MEDICAL OFFICER Apr 01 '24 Option Exercise 0.60 442 265 11,911 Apr 03 04:21 PM Nash Huw M. COO & CBO Apr 01 '24 Sale 13.23 61,329 811,212 0 Apr 03 04:19 PM Ticho Barry CHIEF MEDICAL OFFICER Apr 01 '24 Sale 13.23 9,426 124,684 2,485 Apr 03 04:21 PM Allan Jonathan GENERAL COUNSEL & CORP SEC Mar 28 '24 Sale 13.20 5,126 67,668 2,598 Apr 01 04:14 PM Kaye Edward M. MD CEO Mar 19 '24 Sale 6.10 11,150 67,999 69,350 Mar 19 08:30 PM Ticho Barry CHIEF MEDICAL OFFICER Mar 19 '24 Sale 6.10 4,116 25,102 11,469 Mar 19 08:34 PM Nash Huw M. COO & CBO Mar 19 '24 Sale 6.10 4,116 25,102 11,329 Mar 19 08:31 PM Tulipano Stephen J CFO Mar 19 '24 Sale 6.10 4,116 25,102 20,746 Mar 19 08:36 PM Allan Jonathan GENERAL COUNSEL & CORP SEC Mar 19 '24 Sale 6.10 2,349 14,326 7,724 Mar 19 08:29 PM Ticho Barry CHIEF MEDICAL OFFICER Mar 15 '24 Option Exercise 0.00 13,100 0 15,585 Mar 19 08:34 PM Tulipano Stephen J CFO Mar 15 '24 Option Exercise 0.00 13,100 0 24,862 Mar 19 08:36 PM Nash Huw M. COO & CBO Mar 15 '24 Option Exercise 0.00 13,100 0 15,445 Mar 19 08:31 PM Kaye Edward M. MD CEO Mar 15 '24 Option Exercise 0.00 35,500 0 80,500 Mar 19 08:30 PM Allan Jonathan GENERAL COUNSEL & CORP SEC Mar 15 '24 Option Exercise 0.00 7,475 0 10,073 Mar 19 08:29 PM Ticho Barry CHIEF MEDICAL OFFICER Mar 01 '24 Option Exercise 0.60 5,504 3,302 12,485 Mar 05 04:21 PM Ticho Barry CHIEF MEDICAL OFFICER Mar 01 '24 Sale 7.75 10,000 77,469 2,485 Mar 05 04:21 PM TZIANABOS ARTHUR Director Feb 13 '24 Option Exercise 2.19 31,739 69,508 31,739 Feb 15 04:17 PM Ticho Barry CHIEF MEDICAL OFFICER Feb 01 '24 Sale 4.80 10,000 47,991 6,981 Feb 05 04:32 PM Ticho Barry Chief Medical Officer Jan 02 '24 Sale 5.74 10,000 57,352 16,981 Jan 04 04:38 PM Ticho Barry Chief Medical Officer Jul 03 '23 Sale 10.60 15,000 158,973 25,895 Jul 06 05:20 PM Allan Jonathan General Counsel & Corp Sec Jun 21 '23 Sale 13.48 1,948 26,252 0 Jun 23 04:45 PM Ticho Barry Chief Medical Officer Jun 01 '23 Sale 11.13 15,000 166,964 40,895 Jun 05 07:31 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite